Athersys closing in on commercialization of its stem cell therapy
The Cleveland company said its Japanese partner has completed follow-up examinations of ischemic stroke patients who were treated with MultiStem.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Mary Vanac Source Type: news
More News: Biotechnology | Health Management | Ischemic Stroke | Japan Health | Stem Cell Therapy | Stem Cells | Stroke